share_log

Brainstorm Cell Therapeutics将于2024年10月1日除权除息,15股合为1股

Brainstorm Cell Therapeutics To Carry Out 1-for-15 Reverse Stock Split On October 1st, 2024

Futu News ·  Sep 28 07:35

September 27th (Eastern Time) - $Brainstorm Cell Therapeutics (BCLI.US)$ is about to implement a 1-for-15 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from October 1st, 2024.

$Brainstorm Cell Therapeutics (BCLI.US)$ rose 4.26% and closed at $0.2545 on September 26th with a turnover of $44,603. $Brainstorm Cell Therapeutics (BCLI.US)$ now has a total market capitalization of $20.29 million.


What Is a Reverse Stock Split?

A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.

Note:

The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment